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Novel Modulation of Neuronal Nicotinic
Acetylcholine Receptors by Association
with the Endogenous Prototoxin lynx1
al., 1999) and showed that it alters the function of nico-
tinic receptors in vitro. lynx1 adopts the three-fingered
toxin fold characteristic of -neurotoxins, such as the
bungarotoxins, which bind to and irreversibly inhibit
nAChRs (Sine, 1997; Grant et al., 1998; Hall, 1999) and
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interested in studying the mechanisms by which lynx1
modulates nAChRs. Given the critical roles of nAChRs
in complex brain function (Everitt and Robbins, 1997;Summary
Lindstrom, 1997; Changeux et al., 1998) and the obser-
vations that nAChR mutations can severely disrupt CNSWe previously identified lynx1 as a neuronal mem-
brane molecule related to snake -neurotoxins able function (Steinlein et al., 1995; Phillips et al. 2001), evi-
dence for a novel modulator for the cholinergic pathwayto modulate nAChRs. Here, we show that lynx1 colo-
calizes with nAChRs on CNS neurons and physically could have important physiological implications.
In this study, we use biochemical and electrophysio-associates with nAChRs. Single-channel recordings
show that lynx1 promotes the largest of three current logical approaches to establish the mechanism of action
of lynx1 on nAChRs. We demonstrate that lynx1 colocal-amplitudes elicited by ACh through 42 nAChRs and
that lynx1 enhances desensitization. Macroscopic re- izes with nAChRs on the somatodendritic membrane of
many neurons and that lynx1 can bind directly tocordings quantify the enhancement of desensitization
onset by lynx1 and further show that it slows recovery nAChRs. Furthermore, single-channel recordings from
mammalian cells expressing lynx1 and 42 nAChRs re-from desensitization and increases the EC50. These
experiments establish that direct interaction of lynx1 veal that lynx1 promotes the largest of three current
amplitudes and enhances desensitization. Recordingswith nAChRs can result in a novel type of functional
modulation and suggest that prototoxins may play im- of macroscopic currents in Xenopus oocytes quantify
the acceleration of desensitization onset and furtherportant roles in vivo by modulating functional proper-
ties of their cognate CNS receptors. show that lynx1 slows recovery from desensitization and
increases the EC50 for activation by ACh. These novel
actions of lynx1 suggest that it and other members ofIntroduction
this large gene family, including those expressed in the
mammalian (Horie et al., 1998; our unpublished data)Neuronal excitability mediated through ligand-gated
neurotransmitter receptors is fine-tuned by a complex and invertebrate (Chou et al., 2001) nervous systems,
encode a new mechanistic class of receptor modulatoryarray of modulatory mechanisms. These mechanisms
exist in a hierarchy of control systems from classical proteins.
neuromodulators, circulating hormones, and enzymes
to mechanisms that alter the conformation of the recep- Results
tor such as phosphorylation, subunit composition, and
assembly cofactors. Neuromodulators potentially could Immunohistochemical Colocalization of lynx1
affect receptor function through a vast repertoire of bio- and Neuronal Nicotinic Receptors
physical alterations such as changes in the conduc- lynx1 is enriched in discrete neuronal populations, simi-
tance, open time, rate of desensitization, ligand affinity, lar to patterns of nAChR distribution previously reported
and ionic selectivity of the receptor. Alternative forms (Hill et al., 1993; Dominguez del Toro et al., 1994; Naka-
of regulation have recently come to light, such as buff- yama et al., 1995; Rogers et al., 1998). We were particu-
ering of ACh by glial secretion of a soluble Ach-binding larly interested in establishing an in vivo association of
protein, AChBP (Smit et al., 2001). lynx1 with nicotinic receptors. 17 nAChR subunits have
We previously reported the presence of an endoge- been cloned from vertebrates (Lukas et al., 1999; El-
nous prototoxin, lynx1, in the mammalian CNS (Miwa et goyhen et al., 2001); five of them are expressed in skele-
tal muscle and the other 12 in the CNS and PNS. The
most abundant subtypes in the CNS are 42 and 75 Correspondence: heintz@rockefeller.edu
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nAChRs (Role and Berg, 1996). We performed double-
label immunofluorescence studies on mouse brain sec-
tions to determine whether lynx1 and nAChRs con-
taining 4 and 7 subunits colocalize in the same
neurons.
Experiments were done using both monoclonal anti-
bodies raised against purified recombinant lynx1 protein
and affinity-purified polyclonal antibodies raised against
a lynx1 peptide (see Experimental Procedures). The
lynx1 monoclonal antibody (mAb 8589) used in this study
was chosen because it specifically stained cells trans-
fected with a lynx1 expression vector (Figures 1A and
1B) and because immunohistochemical studies re-
vealed a pattern of staining similar to that obtained for
lynx1 by in situ hybridization (Miwa et al., 1999; data
not shown). The lynx1 polyclonal antibody has been
previously reported (Miwa et al., 1999). For this study,
the crude antiserum was further purified on a peptide
affinity column. The specificity of the purified polyclonal
antibody for lynx1 was tested by comparative immuno-
fluorescence studies on mouse brain sections (Figure 2)
and Western blot (Figure 4). The results of these studies
establish that both antibody preparations recognize
lynx1.
To determine whether lynx1 and the nAChR 4 subunit
are colocalized on the surface of CNS neurons, double-
immunoflourescence experiments were performed us-
ing the lynx1 monoclonal antibody (mAb 8589) and anti-
4 nAChR polyclonal antibody (Rogers et al., 1998). Colo-
calization of lynx1 and the 4 nAChR was evident in
specific subsets of neurons in multiple regions within
the CNS (Figures 1C–1F). Particularly strong labeling
was detected in cerebral cortex, thalamus, substantia
nigra, and cerebellum. In the telencephalon, prominent
double-label immunofluorescence was detected on the
Figure 1. lynx1 Colocalizes with 4 Nicotinic Receptors in the So-membranes of the soma and apical dendrites of deep-
matodendritic Compartment of Several CNS Neurons
layer cortical pyramidal cells (Figure 1C) and basolateral
(A and B) HEK 293T cells were either untransfected (A) or transfected
amygdala neurons (Figure1D). The thalamus exhibited with a lynx1 expression vector (B), stained with the anti-lynx1 mAb
high and widespread double immunoreactivity for lynx1 8589, and viewed with bright field (left) or with fluorescence (right)
and4-containing receptors, including cells of the reticu- optics. Specific rim immunostaining is observed in lynx1 transfected
cells.lar and ventroposterior thalamic nucleus and habenular
(C–F) Distribution of lynx1 and 4 nAChR subunit immunoreactivity incomplex (Figure 1E). In the ventral mesencephalon,
multiple regions within the CNS. Mouse brain sections were doublemost neurons of the substantia nigra (Figure 1F) and
stained with the anti-lynx1 mAb 8589 (green) and with an anti-4globus pallidus (data not shown) showed specific dou- antiserum (red). Merged images are shown in the third column. High-
ble staining. Similar colocalization results were obtained power confocal photomicrographs of cerebral cortex (C), amygdala
using different secondary antibodies. No staining was (D), habenular complex (E), and substantia nigra (F) show strong
double immunofluorescence in the soma and dendritic processesdetected when the primary antibodies were omitted
of distinct neurons. (C) and (F) are sagittal sections, and (D) and (E)(data not shown). Because 4 and 7 nAChR subunits
are coronal sections.can be coexpressed in some CNS cell types (Dominguez
Scale bars correspond to 12.5 m.
del Toro et al., 1994; Nakayama et al., 1995; Rogers et
al., 1998), we also looked for colocalization of lynx1 and
7 nAChRs. Double-immunofluorescence experiments lynx1 Forms a Stable Complex
of lynx1 and the nAChR 7 subunit were performed using with Nicotinic Receptors
the affinity-purified lynx1 polyclonal antibody and the To determine whether lynx1 can form a stable complex
anti-7 nAChR monoclonal antibody mAb 306 (Schoep- with nAChRs, we performed coimmunoprecipitation ex-
fer et al., 1990). lynx1 colocalizes with 7 receptors on periments using HEK 293T cells expressing lynx1 and 7
the surface of many neurons, including those of the or Flag-tagged 4 and 2 nAChRs (Figure 3). Membrane
cerebral cortex (Figure 2B), amygdala (Figure 2C), CA3 fractions were isolated from cells transfected with only
hippocampal neurons (Figure 2D), and reticular thalamic lynx1 (Figure 3A) or with lynx1 and the indicated nAChRs
nucleus (Figure 2E). These results establish that lynx1 (Figures 3B and 3C). After detergent extraction of the
localizes to neurons expressing multiple types of Triton X-100 insoluble membrane fractions, nAChR sub-
nAChRs, indicating the potential of lynx1 to modulate units were immunoprecipitated by incubation with pro-
tein G beads bound to either 7 (IP7) or 4 (IP4) mono-nAChR function.
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with extracts from cells transfected with lynx1 only (Fig-
ure 3A) demonstrated that lynx1 was not precipitated
in the absence of the receptor, with protein G beads
alone, or with beads carrying the 7 monoclonal antibod-
ies. These results demonstrate that lynx1 can form a
stable complex with nAChRs in mammalian cells.
To test the specificity of lynx1 association with nico-
tinic receptors, we used the same immunoprecipitation
protocol to look for association of lynx1 with the delta
2 glutamate receptor (Grid2). To ensure that the results
of the immunoprecipitations could be directly com-
pared, we used Flag epitope-tagged constructs for all
of the receptor subunits and performed the immunopre-
cipitations for both the 4 and 2 nAChRs and Grid2
using anti-Flag antibody beads. Immunoprecipitation of
extracts from cells expressing the Flag-tagged 42 re-
ceptors and lynx1 or Flag-tagged Grid2 receptors and
lynx1 significantly enriched both receptor types in the
precipitate relative to the input fraction (Figure 3D). In
contrast, lynx1 was enriched only in the precipitates
from cells also expressing the 42 receptors, but not
in extracts from cells coexpressing the Grid2 receptors.
As an additional control for the specificity of the inter-
action between lynx1 and nAChRs, we tested whether
these receptors could be precipitated with a second
unrelated GPI-anchored protein. Immunoprecipitation
of extracts from cells transfected with42 receptors and
the GPI-linked protein placental alkaline phosphatase
(PLAP), under conditions identical to those used to re-
veal the interaction of the42 nAChR and lynx1, demon-
strated clear precipitation of the 4 and 2 subunits with
the anti-Flag antibodies, as expected, but did not result
in coprecipitation of PLAP (Figure 3E). This result dem-
onstrates that the association of lynx1 and nAChRs does
not result from adventitious coprecipitation due to non-
specific colocalization of nAChRs and GPI-anchored
proteins in lipid rafts or other membrane subdomains.
Taken together, these experiments establish that lynx1
Figure 2. Specific CNS Neurons Show lynx1 and 7 Nicotinic Recep- can form specific and stable complexes with both of
tor Double Immunoreactivity the major subtypes of neuronal nAChRs.
(A) Double immunofluorescence with two lynx antibody preparations
show similar labeling at the membrane. Mouse brain sections were
lynx1 Alters Single-Channel Currentsdouble stained with affinity-purified anti-lynx1 polyclonal antibody
through 42 nAChRs(green) and anti-lynx1 mAb 8589 (red). The individual and merged
confocal images of CA3 hippocampal neurons reveal immunoreac- We previously observed that application of soluble lynx1
tivity to both antibodies at the somatic membrane. to 7 and 42 nAChRs increased ACh-evoked currents
(B–E) Distribution of lynx1 and 7 subunit immunoreactivity in differ- (Miwa et al., 1999). The immunoprecipitation data dem-
ent CNS areas. Double-staining fluorescence on mouse sagittal
onstrate that native GPI-anchored lynx1 is present inbrain sections was done with affinity-purified anti-lynx1 polyclonal
membrane fractions and that it can form a stable com-antibody (green) and with anti-7 mAb 306 (red). Merged images are
plex with nAChRs. Prompted by these results, we exam-shown on the third column. High-power confocal photomicrograph
of cortical pyramidal neurons (B), cells of the amygdala (C), CA3/CA1 ined the effects of lynx1 on nAChR function when coex-
hippocampal neurons (D), and thalamic reticular nuclei (E) indicate pressed in its native GPI-anchored form with 42
marked colocalization of lynx1 and 7 at the cell membrane of indi- receptors. To determine whether lynx alters the function
vidual neurons.
of individual receptors, we carried out expression ex-Scale bars correspond to 12.5 m.
periments in cultured mammalian cells and recorded
ACh-induced single-channel currents. Using the cell-
attached mode of recording and a range of ACh concen-clonal antibodies. Immunodetection with a polyclonal
7 antibody (Figures 3A and 3B) and with an antibody trations in the recording pipette (10–100 M), we regularly
observed single-channel currents from cells transfectedagainst the Flag epitope (Figure 3C) showed that 7 and
42 receptors were specifically immunoprecipitated. with 4 and 2 cDNAs. However, unitary events were
extremely rare when lynx1 cDNA was included in theImmunoblot analysis of the same fractions with a lynx1
polyclonal antibody (lower panels) demonstrated that transfection (data not shown). We reasoned that the
cell-attached mode of recording allowed steady statelynx1 coimmunoprecipitates with both 7 (Figure 3B)
and with 42 nAChRs (Figure 3C). Control experiments exposure to ACh, which desensitized receptors to a
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greater extent in the presence of lynx1. Thus, rapid appli-
cation of ACh was required to assess the consequences
of lynx1 on single 42 receptors. Using the outside-out
patch mode of recording (Hamill et al., 1981), we locally
perfused each patch with 100 M ACh and observed
single-channel currents due to 42 receptors in both
the presence and absence of lynx1 (Figure 4). In both
the presence and absence of lynx1, ACh elicited an
instantaneous flurry of channel activity that decayed in
frequency over several seconds. However, in the pres-
ence of lynx1, the initial peak of channel activity decayed
more rapidly and completely vanished within less than
10 s following the start of ACh application (Figure 4A).
By contrast, without lynx1, channel events could be
observed for tens of seconds following ACh application.
These results suggest that lynx1 enhances the rate and
extent of desensitization of 42 nAChRs. Analysis of
the current traces reveals that in the absence of lynx1,
ACh elicits currents with three discrete amplitudes: large
(Alg), intermediate (Aint), and small (Asm) (Figure 4A). Com-
parison of the current traces and quantitation using all-
points histograms revealed a second effect of lynx1 on
these receptors. In particular, lynx1 markedly increases
the fraction of currents with large amplitude (Figure 4B).
Computation of relative areas in the all-points histo-
Figure 3. lynx1 Forms a Stable Complex with Nicotinic Receptors grams revealed an increase in the ratio of intermediate-
to high-conductance channels from 1.0:0.22 in the ab-Western blot analysis of the fractions obtained from membrane-
enriched extracts prepared from HEK 293T cells transfected with sence of lynx1 (mean results from two patches) to
either only lynx1(A), 7 nAChR and lynx1(B), Flag-tagged 4 and 2 1.0:1.98 in the presence of lynx1 (mean results from four
nAChR and lynx1 (C and D), Flag-tagged delta 2 glutamate receptor patches) or about a 10-fold increase. This shift toward
(Grid2) and lynx1 (D), or Flag-tagged 4 and 2 nAChR and GPI- larger current amplitude in the presence of lynx1 couldlinked PLAP (E) expression constructs. The first lane in each blot
reflect either an increase in the number of events withcontains a sample of the cell extract input, indicated by the letter
large amplitude or an increase in the mean duration ofI. The immunoprecipitate fractions obtained by incubation of the
indicated cell extracts with only protein G beads (pG) or with protein large amplitude events. No differences in the mean open
G beads coupled to the monoclonal antibodies: anti-7 (IP7), anti-4 duration could be detected for the large amplitude cur-
(IP4), or anti-Flag M2 (IPFlag) are shown in the next lanes. rents recorded in the absence or presence of lynx1 (Fig-
(A) Western blot probed with 7 polyclonal antibody (upper panel) ure 4C). We conclude that lynx1 promotes large ampli-does not detect any specific band. Incubation of the same blot with
tude ACh-evoked currents through 42 nAChRs. Thus,affinity-purified lynx1 polyclonal antibody (lower panel) reveals a
single-channel recordings reveal two novel neuromodu-doublet of bands corresponding to lynx1, migrating at 11–13 kDa
in the I fraction, and not in the pG or IP7 fractions, indicating that latory actions of lynx1 on 42 nAChRs: enhancement
lynx1, when expressed alone, does not bind to either protein G of desensitization and promotion of large amplitude cur-
beads or to 7-bound beads. rents.
(B) Western blot probed with 7 polyclonal antibody (upper panel)
detects a specific band corresponding to 7 at 52 kDa in the I and
lynx1 Alters the Macroscopic PropertiesIP7 fractions, indicating that 7 mAb beads immunoprecipitate 7
of nAChRs in Xenopus Oocytesreceptors. Incubation of the same blot with lynx1 antibody (lower
panel) immunodetects lynx1 also in the I and IP7 fractions, demon- Single-channel recordings suggest that lynx1 enhances
strating that lynx1 coimmunoprecipitates with 7 receptors. desensitization of 42 nAChRs. However, due to slow
(C) Western blot probed with Flag-HRP antibody (upper panel) rundown of nAChR channel events in isolated patches,
shows two specific bands corresponding to 4 at 69 kDa and 2 quantitative effects of lynx1 on desensitization couldat 45 kDa subunits in I and IP4 fractions, indicating that 4 mAb
not be determined. Thus, to quantify the effects of lynx1beads are able to immunopreciptate both 4 and 2 molecules. The
on desensitization, we used the two-electrode voltagesame blot incubated with lynx1 antibody (lower panel) immunode-
tects lynx1 in the precipitate fraction, demonstrating that lynx1 forms clamp to record macroscopic currents from Xenopus
a stable complex with 42 nicotinic receptors. oocytes expressing 42 nAChRs with or without lynx1.
(D) Comparison of lanes I and IPFlag in the blot probed with anti-Flag Following application of ACh, inward currents rapidly
antibody (upper panel) reveals an enrichment of both receptor types,
peaked and then decayed with a biphasic time course42 nAChR and Grid2, in the precipitate fractions relative to the
to a steady plateau current. This biphasic profile wasinput fractions. Grid2 is indicated as 2 and migrates at 114 kDa.
observed regardless of whether lynx1 was coexpressedThe same blot incubated with lynx1 antibody (lower panel) shows
that lynx1 is markedly enriched in the IPFlag fraction from cells coex- with 42 receptors (Figure 5A) and is well-described by
pressing lynx1 with 42 nicotinic receptors, but not from cells coex-
pressing lynx1 with the glutamate receptor Grid2, demonstrating the
specificity of lynx1 coimmunoprecipitation with nicotinic receptors.
(E) Western blot probed with anti-Flag antibody (upper panel) reveals panel) immunodetects PLAP in the input fraction, but not in the
the two bands corresponding to 4 and 2 subunits in the I and IPFlag precipitate fraction, demonstrating that PLAP does not precipitate
fractions. The same blot incubated with a PLAP antibody (lower with 42 nicotinic receptors.
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lynx1 increases both the rate and extent of desensitiza-
tion of 42 receptors.
To ensure that the kinetic effects of lynx1 on 42
receptors reflect a specific modulation of nAChRs by
lynx1, three additional types of control experiments
were conducted. First, the possibility that calcium-acti-
vated chloride currents contaminate the ACh-evoked
currents under our recording conditions was tested. Oo-
cytes were injected with the calcium chelator BAPTA
(Figure 5D) or incubated with the membrane-permeant
form BAPTA-AM (not shown) before recording. No differ-
ences were observed in either of these experiments
when compared to untreated oocytes, either in the pres-
ence or absence of lynx1 (Figure 5A). Second, the speci-
ficity of lynx1 modulation of nAChRs was tested in coex-
pression studies of lynx1 and GABAA (-aminobutyric
acid type A) receptors. GABA-evoked chloride currents
were recorded from oocytes expressing GABAA recep-
tors (112 combination) alone or together with lynx1
using voltage-clamp conditions. As shown in Figure 5E,
no differences in the rate or extent of desensitization of
GABAA receptors were observed. Further experiments
at different GABA concentrations (1, 10, 100 M and 1
mM GABA) revealed no differences in the fitted fast time
constants (data not shown). Finally, the possibility that
lynx1 might also change the capacitance of the oocyte
membrane (Isom et al., 1995) was also examined. No
change in membrane capacitance was observed be-Figure 4. Single-Channel Currents through nAChRs Are Modulated
by lynx1 tween oocytes expressing 42 receptors with or without
Outside-out patches from BOSC cells were locally perfused with lynx1 (217  5 nF and 228  3 nF, respectively, n  5
100 M ACh (see Experimental Procedures). Patches were formed oocytes) (data not shown). We conclude that the effect
from cells expressing either 42 nAChRs (left column) or 42 plus of lynx1 on the kinetics of desensitization of42 nAChRs
lynx1 (right column). reflects an important and novel modulatory role for lynx1
(A) Top traces show currents recorded immediately following ACh
on these receptors. We previously reported that applica-application and are displayed using a compressed time base. Lower
tion of soluble lynx1 to 42 receptors potentiated thetraces show segments from the top traces on expanded time bases,
with the largest (Alg) and intermediate (Aint) current amplitudes indi- ACh-evoked amplitude currents (Miwa et al., 1999).
cated by the dotted lines. Since the efficiency of expression of the receptors from
(B) All-points histograms were obtained from the ACh-evoked cur- a given amount of injected cRNA varies between individ-
rents from the entire trace for each recording; the truncated peaks ual oocytes, we were not able to determine whether
at the far right correspond to baseline current, while the peaks to
coinjected GPI-anchored lynx1 might also potentiatethe left correspond to three amplitudes of unitary currents. Arrows
ACh-evoked currents. To determine whether solubleindicate the largest (Alg), intermediate (Aint), and smallest (Asm) current
lynx1 might also have an effect on the rate of desensiti-amplitudes. For the data illustrated, normalized relative areas of
large, intermediate, and small current amplitudes are as follows: zation, we calculated the time constants of current de-
42, 0.15/1.0/0.17; and 42 plus lynx1, 1.0/0.3/0.21. cay in the original data set of experiments presented
(C) Open-duration histograms for the large conductance currents, for soluble lynx1 application to 42-expressing oocytes
each fitted a single exponential (smooth curves); fitted time con- (Miwa et al., 1999). Two-exponential fit analysis of the
stants are: 42, 0 1.8 ms; and 42 plus lynx1, 0 1.6 ms. Qualita- ACh-evoked currents revealed that application of solu-tively similar results were obtained for five patches from cells ex-
ble lynx1 significantly accelerated the fast time constantpressing 42 and 19 patches from cells expressing 42 plus lynx1.
(before lynx1 application, f 1.76 0.38 s; during lynx1
application, f  0.93  0.2 s, n  11 oocytes). These
the sum of two exponentials (corresponding to the fast data are consistent with an increase in nAChR desensiti-
and slow components) plus a constant. The rate of onset zation in the presence of native GPI-anchored lynx1
of desensitization was quantified by the value of the reported here. However, since soluble lynx1 was applied
time constants, fast (f) and slow (s), obtained in the two- as a pulse in these experiments and since the stability
exponential fits (Figure 5B). The extent of desensitization of its interaction with nAChRs is not known, the dissocia-
was determined by the relative contribution of the fast tion of soluble lynx1 from the receptors during the
component to the total decay (RCf) (Figure 5C). Coex- course of the experiments might also contribute to the
pression of lynx1 with 42 significantly accelerated the kinetics of current decay.
f (42: f  2.73  0.06 s; 42 plus lynx1: f  1.09  To assess whether lynx1 affects ACh sensitivity of42
0.07 s) with no alteration of s (Figures 5A and 5B) and nAChRs, we applied different concentrations of ACh to
increased the RCf (Figures 5A and 5C). Injection of lynx1 oocytes expressing 42 in the presence or absence of
alone or coinjection of lynx1 with either 4 or 2 alone, lynx1. In the presence of lynx1, 42 receptors show
yielded no detectable macroscopic currents in response reduced sensitivity to ACh, compared to 42 alone (Fig-
ure 6A). Dose-response curves generated from the peakto ACh (data not shown). These results indicate that
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currents reveal a shift of approximately 20-fold toward
higher ACh concentrations in the presence of lynx1 (Fig-
ure 6B). From these results, we conclude that coexpres-
sion of lynx1 with 42 nAChRs in oocytes increases the
EC50 for ACh. To further investigate the effect of lynx1
on desensitization of 42 receptors, we used a two-
pulse protocol to examine the time course of recovery
from desensitization induced by ACh. Figure 7A shows
representative traces of the ACh-evoked currents elic-
ited in oocytes expressing either 42 (upper panel) or
42 and lynx1 (lower panel) at increasing times following
wash out of the initial desensitizing dose of ACh. At
short time intervals following wash out of ACh (5–40 s),
the peak amplitude of the second ACh-evoked current
pulse is significantly reduced compared to the initial
pulse in 42 plus lynx1 coinjected oocytes, compared
to 42- expressing oocytes. The time course of recovery
of the second pulse is described by a single exponential
function in both cases. The corresponding time constant
is significantly prolonged in oocytes expressing 42
plus lynx1 (Figure 7B). These results indicate that lynx1
slows recovery from desensitization for 42 receptors.
lynx1 shares the cysteine-rich consensus motif of the
Ly6/neurotoxin superfamily. The disulfide bridges cre-
ated by these conserved cysteines in -neurotoxins cre-
ate a rigid  sheet core from which three variable loops
emerge (Tsetlin, 1999). To assess the structural specific-
ity of lynx1 action on nAChRs we mutated several cyste-
ines in lynx1 that might be critical for its overall topology.
A schematic representation of lynx1, indicating its cyste-
ine bridges, is shown in Figure 8A. We mutated single
cysteines (lynx1 mutants C4, C5, C7, and C9) or two
cysteines (lynx1 mutants C2C3 and C6C7) to alanine to
test the importance of each disulfide bond. We coex-
pressed each lynx1 mutant with 42 nAChRs and exam-
ined the desensitization during application of ACh, as
described in Figure 4C. No enhancement in the extent of
desensitization was observed with lynx1 mutants C2C3,
C4, and C6C7 (Figure 8B). In contrast, coexpression of
lynx1 mutants C5, C7, and C9 with42 receptors caused
Figure 5. lynx1 Enhances Desensitization When Coexpressed with a similar enhancement of the rapidly decaying compo-
Nicotinic Receptors
nent to that observed with wild-type lynx1 (Figure 8B).
(A) Enhanced onset and extent of desensitization during agonist To rule out the possibility that functional differencesapplication is observed when lynx1 is coexpressed with 42 nico-
between lynx1 and lynx1 mutants were due to differen-tinic receptors. Representative ACh-evoked currents in voltage-
tial expression of the lynx1 molecules, extracts fromclamped Xenopus oocytes after coinjection of 4 and 2 cRNAs
subunits with or without lynx1 cRNA. Inward currents were evoked
by 20 s periods of superfusion (horizontal calibration bar), with exter-
nal saline containing 1 mM ACh. The vertical calibration bars corre-
spond to 0.5 A. calcium-dependent currents. Representative ACh-evoked currents
(B and C) Bar graphs representing the values of the parameters in oocytes expressing 42 and 42 plus lynx1 were injected with
obtained by fitting the two-exponential equation: y(t)  [Af 	 exp the calcium chelator BAPTA within 30 min before recording. Qualita-
(
t/f)] [As	 exp (
t/s)]C (f and s, fast and slow time constants; tively similar results were obtained from 8 and 11 oocytes, respec-
Af and As, fraction of the fast and slow components; C, plateau tively.
current) to the inward current decay during agonist application. (B) (E) Coexpression of lynx1 with GABAA receptors does not alter the
Solid bars represent the values of f and open bars correspond to desensitization kinetics of GABA-gated chloride currents. Repre-
s. The values are: 42, f  2.73  0.06 s; 42 plus lynx1, f  sentative GABA-evoked currents in voltage-clamped Xenopus oo-
1.09  0.07 s (Student’s t test; p 1.4 	 10
23) and 42, s  9.14  cytes after coinjection of 1, 1, and 2 GABAA receptor cRNAs sub-
0.05 s; 42 plus lynx1, s  8.96  0.24 s. Values represent the units with or without lynx1 cRNA. Inward currents were evoked by
mean  SEM from 28 and 25 oocytes expressing 42 and 42  10 s periods of superfusion (horizontal calibration bar) with external
lynx1, respectively. (C) Chart indicating the relative contribution of saline containing 10 M GABA. The vertical calibration bars corre-
the fast decay component, RCf, calculated as: RCf  Af/(Af  As  spond to 0.2 A. Two-exponential fit analysis, as described in (B),
C). The values are: 42, RCf  0.06  0.01; 42 plus lynx1 RCf  indicated no significant change in the fitted time constants (GABAA
0.37  0.02 (Student’s t test; p  4.6 	 10
15) and correspond to receptor, f  5.02  0.04 s and s 10.01 0.03 s; GABAA receptor
the mean  SEM obtained from the same oocytes as above. plus lynx1, f  5.13 0.15 s and s 9.9 0.11 s). Values represent
(D) No differences in the ACh-evoked responses were observed in the mean  SEM from nine and seven oocytes expressing GABAA
control experiments to test for the activation of contaminating receptor or GABAA receptor plus lynx1, respectively.
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Figure 6. nAChRs Show Altered Sensitivity to ACh When Coex-
pressed with lynx1
(A) Representative currents induced in Xenopus oocytes after coin-
Figure 7. nAChRs Show Slower Recovery Rate When Coexpressedjection of 4 and 2 cRNAs nAChR subunits with or without lynx1
with lynx1cRNA. Responses to consecutive applications of increasing con-
(A) Representative traces obtained in a two-pulse experiment mea-centrations of ACh are displayed for both 42 (upper panel) and
suring the time course of recovery of ACh-evoked currents in oo-42 with lynx1 (lower panel). Inward currents were evoked by 20 s
cytes injected with 42 (upper panel) or with 42 plus lynx1 (lowerperiods of superfusion (horizontal calibration bar) with external sa-
panel). Two consecutive pulses of ACh (1 mM) were given at theline-containing ACh at the concentrations indicated above each
intervals indicated below each trace. Horizontal and vertical calibra-trace. The vertical calibration bars correspond to 1 A.
tion bars indicate the duration of the agonist application and the(B) Concentration-response curves for ACh on oocytes expressing
magnitude of the currents, respectively.42 (closed triangle) and 42 nAChRs with lynx1 (closed circle).
(B) The relative peak amplitudes (I2/I1) measuring the recovery timeThe dependence of the peak inward amplitude response on the
course of ACh-evoked currents in oocytes expressing 42 nAChRsconcentration of ACh was normalized to the peak amplitude of con-
(closed triangle) and 42 nAChRs with lynx1 (open circle). Eachtrol responses induced by 1 mM ACh. Each plotted value is the
value is the mean  SEM of four oocytes in each case. The continu-meanSEM obtained from seven oocytes. Each ACh concentration
ous curves are fits of a single exponential of the form: I2/I1 [C1	point was tested by three consecutive pulses. The data obtained
exp (
tint/rec)]C2, where I1 and I2 are the peak amplitude responseswere fitted to the following form of the Hill equation: I/Imax [ACh]nH/
of the first and second ACh pulses, C1 and C2 are constants, tint is([ACh]nH  (EC50)nH) (drawn lines). The fitted parameters are: 42,
the length of the interval time, and rec is the recovery time rate. TheEC50 1.8  0.3 M and nH  0.71  0.04; 42 plus lynx1, EC50
relative peaks (I2/I1) recover with the fitted time constants: 42, rec 35  3.9 M and nH  0.82  0.03.
32  2 s; 42 plus lynx1, rec 53  5 s (Student’s t test; p  1.8 	
10
3).
injected oocytes were examined by immunoblotting with
a lynx1 antibody. No significant differences in expres- and low EC50s for ACh and that the low concentration
sion of lynx1 mutants were observed (Figure 8C). These EC50 was associated with receptors with slow desensiti-
results demonstrate that the disulfide bridges C2-C3 zation onset (Buisson et al., 2000; Buisson and Bertrand,
and C4-C6 are required for lynx1 to promote desensitiza- 2001); fast and slow rates of desensitization onset have
tion of ACh-evoked currents through 42 nAChRs. also been observed (Buisson et al., 1996). Furthermore,
two predominant current amplitudes were observed
(Kuryatov et al., 1997; Buisson and Bertrand, 2001). OurDiscussion
results show a similar association between the low ACh
concentration EC50 and slow desensitization, and ourThe present results establish that lynx1 functions as a
novel modulator of neuronal nAChRs. lynx1 colocalizes two predominant current amplitudes coincide with those
previously observed.with both 42 and 7 nAChRs on a variety of neuronal
subtypes in mouse brain, and it stably associates with Coexpression of lynx1 with 42 nAChRs leads to a
more homogeneous distribution of current amplitudes,these receptors in cultured mammalian cells. We find
that coexpression of lynx1 with 42 nAChRs shifts the with the large amplitude currents predominating, but
lynx1 does not affect the kinetics of channel closing.distribution of current amplitudes to a more uniform
and larger amplitude, increases the EC50 for ACh-evoked Coincident with the shift in current amplitude is a shift
to a high ACh concentration EC50 and enhancement ofcurrents, and alters the kinetics and extent of desensiti-
zation. Because mutations in neuronal nAChRs that af- desensitization. Thus, the modulatory effect of lynx1
maintains the 42 nAChR in the high-conductance,fect their kinetics severely impair CNS function, our re-
sults strongly suggest that lynx1 may play an important high-EC50, and strongly desensitizing conformation. Be-
cause no single underlying mechanism relates currentrole in modulating central cholinergic function.
Previous studies of 42 nAChRs demonstrated high amplitude, EC50 and desensitization, we conclude that
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competitive antagonist dihydro--erythroidine (Buisson
and Bertrand, 2001). Our overall results suggest that
lynx1 opposes the changes in functional properties in-
duced by chronic exposure to nicotine. Thus, lynx1
might be important in the response to chronic nicotine
exposure in vivo.
The major effects of lynx1 modulation of nicotinic re-
ceptors are to change a wide spectrum of functional
properties of 42 receptors. Mutations in human 4 and
2 subunits have been genetically linked to autosomal
dominant nocturnal frontal lobe epilepsy (ADNFLE)
(Steinlein et al., 1995; Phillips et at., 2001). Effects of
these mutations on 42 receptors show that they also
strongly affect the kinetic properties of the receptors
in vitro, leading to increased desensitization, slowed
recovery, impaired calcium permeability, and changes
in the single-channel conductance (Weiland et al., 1996;
Kuryatov et al., 1997; Figl et al., 1998). Since alterations
of this nature have important neurological effects, the
actions of lynx1 on some of these aspects of nicotinic
receptor activity point to an important role for lynx1 in
nervous system function.
Our data demonstrate that lynx1 can form a stable
Figure 8. Mutation of Individual Cysteines Indicate that Two of the complex with nicotinic receptors and that it colocalizes
Five Cysteine Bridges in lynx1 Are Critical for Its Activity
with these receptors in neurons. Although we do not yet
(A) Three-dimensional model of lynx1 showing the five disulfide know all the receptors lynx1 can modulate, our resultsbridges and the C and N termini of the molecule. The cysteine bonds
establish preferential binding to 7 and 42 nAChRs.are between cysteines 1 and 5, cysteines 2 and 3, cysteines 4 and
This physical association indicates that lynx1 could po-6, cysteines 7 and 8, and cysteines 9 and 10.
(B) Single cysteines (lynx1 mutants C4, C5, C7, and C9) or two tentially alter the function of these receptors in vivo. The
cysteines (lynx1 mutants C2C3 and C6C7) were mutated to alanines attachment of lynx1 to the cell surface by a GPI-anchor
in lynx1 to test the importance of each disulfide bond. The ACh- and its somatodendritic localization have important im-
gated currents obtained from oocytes coinjected with only 42 plications regarding the mechanism of lynx1 action. Un-
nAChRs (
) with 42 and wild-type lynx1 (wt) or with 42 and like conventional secreted neurotoxins and neuromodu-lynx1 mutants (C2C3, C4, C5, C6C7, C7, and C9) were analyzed for
latory proteins, lynx1 action may operate on receptorsdifferences in the relative contribution of the fast decay component
present in the same subcellular domains. Localization(RCf), as described in Figure 5C. The values obtained are plotted in
the bar graph. Each value is the mean SEM of seven to 12 oocytes. of lynx1 to the cell membrane can allow it to be pre-
(C) Western blot analysis of lynx1 immunodetected protein on oo- sented at a high local concentration to its target recep-
cytes injected with lynx1 or lynx1 mutants. Extracts from uninjected tors to facilitate biologically robust effects. It also pre-
control oocytes (CTL) were loaded in lane 1. Extracts from oocytes sents opportunities for dynamic modulation of receptorsinjected with wild-type lynx1 (wt) or with the different lynx1 cysteine
at the cell surface that would not be available to secretedmutants (C2C3 to C9) are loaded in the following lanes.
modulatory proteins. Furthermore, since GPI-anchors
are covalently attached in the endoplasmic reticulum
and the modified proteins are transported through the
the action of lynx1 arises through a profound global secretory pathway to the cell surface, lynx1 also has the
change in receptor conformation. opportunity to associate with receptors during assembly
Whereas lynx1 appears to function by maintaining low and transport. Previous studies on the functional char-
ACh sensitivity, a high signal to noise ratio, and a good acterization of nAChRs have shown that variations in
safety margin to ACh exposure, chronic exposure to subunit type and : stoichiometry can affect the rate
nicotine opposes maintenance of this multifaceted func- of decay and EC50 of ACh-evoked currents (Ramirez-
tional state. Nicotine exposure shifts the EC50 to low LaTorre et al., 1996; Gerzanich et al., 1998; Zwart and
ACh concentrations, slows the onset of desensitization, Vijverberg, 1998). It has been proposed that some of
and increases the number of high-affinity epibatidine these structural changes can influence the ability of the
binding sites (Buisson and Bertrand, 2001). These ef- receptor to make concerted changes in conformation
fects are not due to changes in receptor mRNA expres- that are required for channel opening or desensitization.
sion (Marks et al., 1992) or to changes in the concentra- If lynx1 can act during processing and transport of re-
tion of receptors in the membrane (Whiteaker et al., ceptors to the cell surface, one might expect that those
1998). Rather, it has been proposed that long-term expo- receptors reaching the cell surface represent a limited
sure to nicotine induces an isomerization of nAChRs subset of all possible combinations available, based on
from a low- to a high-affinity state (Buisson and Ber- subunit expression profiles. In this case, the role of lynx1
trand, 2001). The effect of chronic nicotine exposure on could be to enhance the uniformity of the cellular re-
single-channel conductance remains to be fully exam- sponse to ACh by selecting specific forms of the recep-
ined, but the two predominant current amplitudes char- tor to be presented at the cell surface, thereby modu-
acteristic of 42 nAChRs were observed without nico- lating the functional response of these receptors.
Alternatively, lynx1 could enhance the rate of assemblytine exposure, as well as following upregulation with the
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monoclonal cell lines were screened by Western blot analysis, im-of nAChR subunits and/or increase the probability of
munofluorescence analysis on cells transfected with a CMV-lynx1insertion into the membrane. Although these mecha-
plasmid, and immunocytochemical analysis on mouse brain sec-nisms could account for some of the effects of lynx1, it
tions. Ascites fluid against this cell line (lynx1-1) was purified on a
is evident that the role of lynx1 is not to act solely as a ProA column to a final concentration of 17 mg/ml.
chaperone, as lynx1 can be found in high quantities
at the cellular periphery. Indeed, we have previously Immunohistochemistry
reported that lynx1 can increase macroscopic currents Experiments were done using a monoclonal antibody (mAb 8589)
and an affinity-purified polyclonal antibody against lynx1, an anti-4when applied in soluble form, demonstrating its ability
nAChR polyclonal serum (Flores et al., 1992), and a monoclonalto act on preformed 7 and 42 receptors.
against 7 nAChR (mAb 306, SIGMA). 1-month-old mice (Inbred F1In conclusion, we present strong evidence demon-
hybrid CBA/J	C57Bl/6) were perfused with saline, 0.2% paraform-
strating that lynx1 can modulate important properties aldehyde/PBS, and 2% paraformaldehyde/5% sucrose/PBS. Dis-
of nAChRs. lynx1 is present in the same cellular loca- sected brains were sectioned at 50 m on a freezing microtome.
tions as neuronal nicotinic receptors, it can directly as- Double-immunofluorescence experiments with lynx1 and 4 nAChR
were done by incubating free-floating sections with 4 antiserum at asociate with these receptors, and alter their responses
1:1600 dilution overnight at 4C, washing and subsequent incubationto ACh. Studies of mice carrying lynx1 null mutations
with anti-rabbit Cy3-conjugated antibody for 1 hr at RT. Next, sec-will allow us to further establish a role for this modulator
tions were extensively washed, processed following the M.O.M. kit
in CNS function in mammals. The existence of many (Vector Lab) instructions, and incubated with lynx1 mAb 8589 at a
lynx1-like CNS expressed genes in the mammalian and 1:30,000 dilution for 1 hr at 4C, washed, and incubated with Cy5-
invertebrate genomes (our unpublished data), the novel conjugated anti-mouse antibody for 1hr at RT. Double-immunofluo-
rescence experiments with lynx1 and 7 nAChR were done usingmechanistic properties of lynx1 that we have reported
the affinity-purified polyclonal antibody against lynx1 diluted 1:10here, and the demonstration that a lynx1-like gene
and Cy3-conjugated goat anti-rabbit antibody, followed by incuba-(odr-2) is expressed at high levels in sensory and motor
tion with 7 mAb 306 according to M.O.M. (Vector Lab) manufacturerneurons in C. elegans and is required for chemotaxis in instructions at a 1:100 dilution and Cy5-conjugated anti-mouse anti-
response to olfactory cues (Chou et al., 2001) support body. Sections were mounted on microscope slides and imaged on
the idea that this class of neuromodulatory proteins may a BioRad Radiance 2000 confocal microscope.
have diverse roles in the CNS.
Expression and Immunoprecipitation from HEK 293T Cells
HEK 293T cells were transfected by calcium phosphate precipitationExperimental Procedures
with the expression vectors containing the cDNAs of lynx1, 7
nAChR, Flag-tagged 4 and 2 nAChR subunits, Flag-tagged Grid2,Constructs
and GPI-linked PLAP . Two days after transfection, cells wereThe cDNA sequence encoding mouse lynx1 flanked by its 3 and
washed with PBS, harvested in lysis buffer (150 mM NaCl, 50 mMpart of its 5 untranslated sequences was subcloned into the oocyte
HEPES, 100 mM PMSF, 1.5 g/ml aprotinin, 10 g/ml leupeptin,expression vector pCS2 and used for in vitro transcription and
and protease inhibitor cocktail) containing 1% Triton X-100 andtransfection experiments. lynx1 cysteine mutants were prepared
centrifuged at 14,000 rpm for 5 min. Insoluble cell pellets wereusing the Quick-Change Site-Directed Mutagenesis kit (Stratagene,
resuspended in lysis buffer containing 1% NP40 and 0.05% deoxy-La Jolla, CA). All mutations were verified by sequencing. cDNAs
cholate for 3 hr at 4C and precleared by centrifugation at 14,000encoding nAChR 4, 2, and 7 subunits were a gift from Dr. Marc
rpm for 5 min. Protein G agarose beads (Roche) were used asBallivet. The cDNAs of the GABAA receptor subunits 1, 1, and 2
described by the manufacturer. Essentially, G beads were incubatedwere a gift from Dr. Myles Akabas. The constructs containing 7
with either no antibody or monoclonal antibodies mAb 306, mAband Flag-tagged 4 and 2 nAChR cDNAs were a gift from Dr. Jose´
299, or Flag M2 in NP40/deoxycholate lysis buffer for 3 hr at 4CRamirez-LaTorre. The expression plasmid containing the cDNA of
with gentle rocking. Antibody-bound protein G beads were centrifu-the delta 2 glutamate receptor (Grid2) (Zuo et al., 1997) was Flag-
gated at 5000 rpm for 1 min, supernatants were removed, and thetagged at the N terminus by Dr. Zhenyu Yue. The GPI-anchored
precleared transfected cell extracts were incubated with the anti-PLAP expression plasmid was constructed by Dr. Toshifumi
body-bound G beads overnight at 4C with gentle rocking. AgaroseTomoda.
beads were extensively washed with NP40/deoxycholate lysis buffer
and resuspended in 4	 reducing sample buffer (Invitrogen). CellAntibodies
extracts and protein G fractions were loaded on SDS-PAGE gelsThe rabbit polyclonal antibody against the nAChR 4 subunit was
(Invitrogen) and transferred to PVDF membranes (Immobilon P, Milli-a kind gift from Dr. Scott Rogers. The monoclonal antibodies
pore). Blots were blocked with 5% nonfat milk in PBS with 0.1%FlagM2, mAb 306 anti-7, mAb 299 anti-4, and HRP-coupled anti-
Tween-20 for 30 min and incubated with either polyclonal 7 anti-Flag antibodies were purchased from SIGMA. The polyclonal anti-
body (Santa Cruz), HRP-coupled anti-Flag antibody (SIGMA), or af-body anti-7 was purchased from Santa Cruz Antibodies. Fluores-
finity-purified anti-lynx1 polyclonal antibody overnight at 4C. West-cent-conjugated and HRP-conjugated secondary antibodies were
erns incubated with 7 and lynx1 antibodies were washed in blockingpurchased from Jackson Immunochemicals. The rabbit polyclonal
solution and incubated with the corresponding HRP-conjugatedantibody against human PLAP was purchased from ZYMED. The
secondary antibodies in blocking solution. Blots were extensivelyrabbit polyclonal antibody against lynx1 was obtained as described
washed and developed by cheminoluminiscence using ECL (NENin Miwa et al. (1999) and was affinity purified on a cyanogen bromide
Biolabs).activated Sepharose 4B column (Sigma-Aldrich) coupled to the
lynx1 peptide TTRTYFTPYRMKVRKS according to the manufacturer
instructions. Receptor Expression in BOSC Cells and Recordings
of ACh-Evoked Single-Channel CurrentsMonoclonal Antibody Production
A lynx1-his epitope fusion protein was prepared from BL21(DE3)- BOSC cells were transfected by calcium phosphate precipitation
as described above (Wang et al., 2000). BOSC cells are a cell linepLys cells transformed with pET264 plasmid constructed by sub-
cloning mature, secreted lynx1 (without the signal sequence or GPI- variant of the HEK 293T cell line (Pear et al., 1993). nAChR cDNAs
were cotransfected with the cDNA encoding Green Fluorescent pro-anchor sequence) into the XhoI site of the pET14b bacterial expres-
sion vector (Novagen). IPTG-induced cell lysates were denatured tein to facilitate identification of transfected cells. Transfected cells
were bathed in depolarizing buffer containing 142 mM KCl, 5.4 mMin 8 M Urea, purified on nickel beads (Qiagen), and renatured by
sequential 2-fold dilutions in PBS. This lynx1-his fusion protein was NaCl, 1.8 mM CaCl2, 1.7 mM MgCl2, 10 mM HEPES (pH 7.4) and
cell-free outside-out patches were formed as described (Hamill etinjected into mice (Green Mountain Antibodies, Burlingtion, VT), and
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al., 1981) using the patch pipette buffer 80 mM KF, 20 mM KCl, 40 cRNA injected for these expression control experiments was 5–6
times greater than that used in two-electrode voltage clamp experi-mM K aspartate, 2 mM MgCl2, 1 mM EGTA, 10 mM HEPES (pH 7.4).
To avoid desensitization, a second pipette containing 100 M ACh ments. Injected oocytes were homogeneized in oocyte lysis buffer
(10% glycerol, 1% Triton X-100, 100 mM PMSF, 1.5 g/ml aprotinin,in depolarizing buffer was positioned near the isolated patch imme-
diately before recording, and ACh was applied by pressure injection. and 10g/ml leupeptin in extracellular recording solution). Typically,
20 oocytes were homogeneized in 100 l lysis buffer. HomogenatesACh-evoked currents were recorded with an Axoclamp 200B, digi-
tized at 100 kHz using the program Acquire, and filtered at 2 kHz were centrifuged for 20 min at 14,000 rpm and the intermediate
phase was collected. Oocyte extracts (15 l) were run in a PAGEfor analysis of all-points and open-time histograms using the pro-
gram TAC (Bruxton Corp.) gel (Novex) and Western blotting was performed as indicated before.
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